Daniel Dea, MD

Pulmonary Disease in Burbank, CA

2701 W Alamed, Suite 601, Burbank, CA 91505
NPI 1013005503 Accepts Medicare assignment Offers telehealth 39 years since graduation Public record — not managed by the clinician

About Dr. Daniel Dea

Dr. Daniel Dea is a physician specializing in pulmonary disease practicing in Burbank, CA, a graduate of University of Chicago, Pritzker School of Medicine (1987). Affiliated with Cedars-Sinai Medical Center, Providence Holy Cross Medical Center, Providence Saint Joseph Medical Ctr and 4 more. Treated 711 Medicare patients in 2024.

SpecialtyPulmonary DiseaseOther pulmonary disease doctors in Burbank
CredentialsMD
EducationUniversity of Chicago, Pritzker School of Medicine, 1987CMS Doctors and Clinicians
GenderMale
NPI number1013005503National Provider Identifier (CMS NPPES), issued October 2006
MedicareEnrolled in Medicare; accepts Medicare assignment (the Medicare-approved amount as full payment)CMS Doctors and Clinicians
TelehealthOffers telehealth servicesCMS Doctors and Clinicians

Where Dr. Daniel Dea practices

Addresses from CMS Doctors and Clinicians (Medicare enrollment). Call before visiting: a clinician may not see patients at every listed address.

Dr. Daniel Dea's specialties and state licenses

Specialty (NPPES)License
Pulmonary Disease PrimaryCA G64208

As reported by the clinician to the NPPES registry. Confirm a license and any disciplinary history with the state medical or licensing board.

Hospital affiliations of Dr. Daniel Dea

  • Cedars-Sinai Medical CenterHospital · Los Angeles, CA
  • Providence Holy Cross Medical CenterHospital · Mission Hills, CA
  • Providence Saint Joseph Medical CtrHospital · Burbank, CA
  • Burbank Healthcare & RehabNursing home · Burbank, CA
  • Eder Home Health Care, Inc.Home health agency · Sherman Oaks, CA
  • Jubilee Home Health Care IncHome health agency · Simi Valley, CA
  • New Century Home Health, IncHome health agency · Simi Valley, CA

CMS Facility Affiliation data: facilities where the clinician bills Medicare.

Dr. Daniel Dea's Medicare patients and services (2024)

711Medicare patients
4,270services billed
77average patient age
55%women

Most frequent services

ServiceTimesAvg. Medicare allowed
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes1,220$122.27
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes996$81.35
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more671$98.31
Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes225$113.45
Test to examine how well the lungs exchange gases176$8.98
Test to determine lung volumes using gas dilution or washout172$12.13
Test to measure expiratory airflow and volume changes before and after medication administration171$10.39
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more167$138.14

Common conditions among these patients

  • High cholesterol75%
  • High blood pressure75%
  • Arthritis69%
  • Ischemic heart disease57%
  • Diabetes53%
  • Heart failure47%

Medicare Part B fee-for-service claims only (CMS Medicare Physician & Other Practitioners, 2024). Patients with private insurance or Medicare Advantage are not counted; small counts are suppressed by CMS. This describes the patients, not the quality of care.

Dr. Daniel Dea's Medicare quality score (MIPS 2024)

100/100final MIPS score
40improvement activities
100cost

The Merit-based Incentive Payment System scores clinicians who bill Medicare. Reported as group. Source: CMS Care Compare, PY 2024 clinician public reporting.

Payments from drug and device companies to Dr. Daniel Dea (2025)

$3,138.03 in 90 general payments reported in 2025.

TypePaymentsAmount
Food and beverage89$2,938.03
Consulting fees1$200

Paying companies: AstraZeneca Pharmaceuticals LP ($542.56), Bayer HealthCare Pharmaceuticals Inc. ($500.30), GlaxoSmithKline, LLC. ($368.85), Genzyme Corporation ($366.06), Boehringer Ingelheim Pharmaceuticals, Inc. ($250.89), Verona Pharma, Inc. ($187.86).

Reported by companies under the federal Open Payments program (CMS, program year 2025). A payment, such as a meal at an educational event, does not mean wrongdoing; clinicians can dispute records with CMS.

Questions about Dr. Daniel Dea

What kind of clinician is Dr. Daniel Dea?

Dr. Daniel Dea is listed as a physician specializing in pulmonary disease.

Where does Dr. Daniel Dea practice?

The main practice address at 2701 W Alamed, Suite 601, Burbank, CA 91505.

What is the office phone number for Dr. Daniel Dea?

The listed office number is (818) 846-2766. Call to confirm availability and whether new patients are accepted.

What is the NPI number of Dr. Daniel Dea?

The National Provider Identifier is 1013005503.

Does Dr. Daniel Dea accept Medicare?

Yes. CMS lists this clinician as accepting Medicare assignment. Confirm your plan with the office.

Which hospitals is Dr. Daniel Dea affiliated with?

Cedars-Sinai Medical Center, Providence Holy Cross Medical Center, Providence Saint Joseph Medical Ctr, Burbank Healthcare & Rehab, Eder Home Health Care, Inc..

Where did Dr. Daniel Dea go to medical school?

University of Chicago, Pritzker School of Medicine, graduating in 1987.

Where this information comes from

CMS Doctors and CliniciansName, specialty, education, Medicare enrollment and practice addresses.Centers for Medicare & Medicaid Services, national downloadable file (2026)
NPPES NPI registryNPI, specialties (taxonomy) and state licenses.CMS National Plan and Provider Enumeration System; record updated 2020-02-12
Facility affiliationsHospitals and other facilities.CMS Doctors and Clinicians facility affiliation file; names from CMS Provider of Services
Medicare utilizationPatients, services and conditions.CMS Medicare Physician & Other Practitioners, 2024
MIPSQuality payment program scores.CMS clinician public reporting, PY 2024
Open PaymentsPayments from drug and device companies.CMS Open Payments, program year 2025

Information is public record and may lag behind changes. Clinicians update it through NPPES and Medicare PECOS. See something wrong? Tell us.

0 clinics selected Compare